Propionyl-L-carnitine for intermittent claudication

The objective of this review is to determine whether propionyl-L-carnitine is efficacious compared with placebo, other active drugs or with any other intervention for intermittent claudication (exercise, angioplasty, surgery) in increasing pain-free and maximum walking distance for patients with stable intermittent claudication, Fontaine stage II.

This is a protocol.